Emerson (EMR) Stock Analysis
NYQ · Industrials · Specialty Industrial Machinery
$158.90
+0.67 (+0.42%)
EMR Interactive Price Chart & Trading Signals
EMR Stock Snapshot — Valuation, Risk & Technical Signals
EMR Key Fundamentals, Analyst Targets & Company Profile
Key Financial Ratios
Market Cap
$88.63B
P/E Ratio
34.77
Forward P/E
21.88
PEG Ratio
1.82
P/B Ratio
4.35
EPS
$4.57
Dividend Yield
1.40%
52W Range
$122.64 – $166.35
Beta
1.23
Volume
0.5M
ROE
12.8%
Profit Margin
13.8%
Revenue Growth
7.0%
Gross Margin
53.2%
EV/EBITDA
16.49
Analyst Target
$173.50
The trailing price-to-earnings ratio stands at 34.8x. Forward P/E of 21.9x implies earnings expansion expected. Price-to-book is 4.35x. EV/EBITDA sits at 16.49x. Market capitalization is $88.63B. Revenue is growing at 7.0% on a trailing basis. Earnings are expanding at 23.0%. Profit margins are 13.8%. Return on equity is 12.8%. Beta of 1.23 indicates elevated market sensitivity.
Analyst Consensus
Recommendation
Buy
Low Target
$104.00
Mean Target
$173.50
High Target
$205.00
Based on 28 analysts
About Emerson
Emerson Electric Co., a technology and software company, provides various solutions in the Americas, Asia, the Middle East, Africa, and Europe. It operates through Final Control, Measurement & Analytical, Discrete Automation, Safety & Productivity, Control Systems & Software, and Test & Measurement segments. The Final Control segment provides control valves, isolation valves, shutoff valves, pressure relief valves, pressure safety valves, actuators, and regulators for process and hybrid industries under Anderson Greenwood, Bettis, Crosby, Fisher, Keystone, KTM, and Vanessa brands. The Measurement & Analytical segment supplies intelligent instrumentation measuring the physical properties of liquids or gases, such as pressure, temperature, level, flow, acoustics, corrosion, pH, conductivity, water quality, toxic gases, and flame under the Flexim, Micro Motion, and Rosemount brands. The Discrete Automation segment includes solenoid valves, pneumatic valves, valve position indicators, pneumatic cylinders and actuators, air preparation equipment, pressure and temperature switches, electric linear motion solutions, programmable automation control systems and software, electrical distribution equipment, and materials joining solutions used primarily in discrete industries under the Afag, Appleton, ASCO, Aventics, Branson, Movicon, PACSystems, SolaHD, TESCOM, and TopWorx brands. The Safety & Productivity segment delivers tools for professionals and homeowners that support infrastructure, promote safety, and enhance productivity under the Greenlee, Klauke, ProTeam, and RIDGID brands. The Control Systems & Software segment provides control systems and software that control plant processes by collecting and analyzing information from measurement devices in the plant under the DeltaV and Ovation brands. The Test & Measurement offers software-connected automated test and measurement systems. The company was incorporated in 1890 and is headquartered in Saint Louis, Missouri.
EMR Deep Dive Analysis
Bottom Line
Verdict
OvervaluedBest for
Higher-risk tolerance investorsWatch out for
Premium valuation, High volatilityNon-zero inputs
4/5Counts non-zero values for price, P/E, beta, macro risk, and revenue growth; zero may mean unavailable or be a genuine zero.
Emerson Electric Co. (EMR) trades above our multi-model fair value estimate of $60.80 by approximately 61.7%. Trailing P/E: 34.8x. Profitability signals include profit margin of 13.8% and return on equity of 12.8%. Recent growth metrics show revenue growth of 7.0% and earnings growth of 23.0%. Risk profile: elevated market beta of 1.23. Consensus: buy.
Valuation, Growth & Risk
Valuation
Overvalued
P/E 34.8x
Price is above what fundamentals suggest.
Growth
Expanding
Rev 7.0%
Revenue is outpacing the market.
Risk
Elevated
Beta 1.23
Expect bigger swings than the market.
Valuation Snapshot
Emerson Electric Co. (EMR) trades above our multi-model fair value estimate of $60.80 by approximately 61.7%. The trailing price-to-earnings ratio stands at 34.8x. Forward P/E of 21.9x suggests earnings compression ahead. Price-to-sales is 4.8x. Price-to-book is 4.3x. EV/EBITDA sits at 16.5x. Market capitalization is $88.63B.
Why it matters: Paying a premium works only if the company keeps growing faster than expected.
Growth & Profitability
Revenue is growing at 7.0% on a trailing basis. Earnings are expanding at 23.0%. Profit margins are 13.8%. Return on equity is 12.8%. Return on assets is 6.9%.
Why it matters: Growing revenue with healthy margins usually means the business is gaining market share or pricing power.
Risk Profile
Beta of 1.23 indicates elevated market sensitivity. Net debt position is $11.62B.
Why it matters: A riskier stock can fall more in a downturn. Make sure your portfolio can handle the volatility.
Analyst Context
Analyst consensus target of $173.50 implies 9.2% upside. Target range spans $104.00 to $205.00. 28 analysts cover the stock. Consensus recommendation: buy.
Why it matters: Analyst targets reflect what professionals expect over 12 months. A wide gap between price and target can mean the market disagrees with the consensus.
Data Methodology & Sources
Market Data (Facts)
- Price, volume, and market cap: Yahoo Finance (may be delayed)
- P/E, EPS, revenue, and debt: Yahoo Finance fundamentals
- Analyst estimates: Yahoo Finance (coverage and update times vary)
- Insider transactions: Yahoo Finance (reporting may be delayed)
QuantSoar Model (Derived)
- Fair value: available outputs from seven models; outliers are filtered using MAD (k=3.5), then combined with fixed model weights.
- Margin of Safety = (Fair Value − Displayed Price) / Displayed Price × 100
- Composite Score: 40% Value + 30% Momentum + 30% Risk
- Verdict Gauge: Base 50 + Valuation (up to ±25) + Whale sentiment (up to ±10) + Insider buying (+5) + Macro risk (up to ±10) + Technical signal (up to ±10). Analyst consensus is separate.
Model outputs are estimates based on available data and are not investment advice. Cross-check with primary sources before making investment decisions.
EMR Overvalued
Emerson Electric Co. (EMR) trades above our multi-model fair value estimate of $60.80 by approximately 61.7%.
Frequently Asked Questions
ValuationIs EMR stock overvalued right now?
ValuationWhat is EMR fair value based on current fundamentals?
RiskHow risky is EMR compared with other stocks?
GrowthIs EMR still growing?
AnalystWhat do analysts think about EMR?
DividendDoes EMR pay a dividend?
CatalystWhat could change the investment case for EMR?
Related Stocks
About the Author
Phasakorn Traklang (Peach) — Founder
Phasakorn Traklang (Peach) is the founder of QuantSoar, bringing expertise in SEO, web development, and technical analytics to build an AI-powered investment platform accessible to retail investors worldwide.
Connect on LinkedInInvestment Disclaimer: Tax treatment can depend on tax residence, account type, and tax year. This information is general and is not personal tax or investment advice. SEC
Data: Yahoo Finance / SEC EDGAR / Alpha Vantage / Finnhub. AI outputs verified against source data.